COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 163 filers reported holding COHERUS BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 1.41 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $325,784 | -2.4% | 87,108 | +9.4% | 0.00% | – |
| Q2 2023 | $333,646 | +193880.2% | 79,629 | +197.1% | 0.00% | – |
| Q1 2023 | $172 | -55.9% | 26,800 | -45.5% | 0.00% | – |
| Q4 2022 | $390 | -99.8% | 49,199 | +284.4% | 0.00% | – |
| Q4 2021 | $214,000 | -34.4% | 12,800 | -44.8% | 0.00% | – |
| Q2 2021 | $326,000 | +100.0% | 23,200 | +105.3% | 0.00% | – |
| Q1 2021 | $163,000 | -58.5% | 11,300 | -45.9% | 0.00% | -100.0% |
| Q3 2020 | $393,000 | -55.1% | 20,900 | -58.1% | 0.00% | -50.0% |
| Q4 2019 | $876,000 | +862.6% | 49,912 | +389.3% | 0.00% | – |
| Q4 2018 | $91,000 | -52.4% | 10,200 | -12.1% | 0.00% | – |
| Q3 2018 | $191,000 | +67.5% | 11,600 | -10.1% | 0.00% | – |
| Q4 2017 | $114,000 | -80.8% | 12,900 | -71.0% | 0.00% | -100.0% |
| Q3 2017 | $595,000 | -50.8% | 44,532 | -46.8% | 0.00% | -50.0% |
| Q2 2017 | $1,209,000 | +381.7% | 83,675 | +840.2% | 0.01% | +500.0% |
| Q4 2016 | $251,000 | – | 8,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 650,000 | $10,374,000 | 2.09% |
| CM Management, LLC | 125,000 | $1,995,000 | 1.51% |
| Perceptive Advisors | 10,815,596 | $172,616,000 | 1.33% |
| Bridge City Capital, LLC | 163,198 | $2,605,000 | 1.07% |
| Phocas Financial Corp. | 514,438 | $8,210,000 | 1.04% |
| Redwood Investments, LLC | 709,184 | $11,319,000 | 0.89% |
| Aristotle Capital Boston, LLC | 2,087,187 | $33,312,000 | 0.78% |
| Knott David M Jr | 102,555 | $1,637,000 | 0.56% |
| Zebra Capital Management LLC | 16,746 | $267,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $117,803,000 | 0.42% |